Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0N3W
|
||||
Drug Name |
4-((3-(2-phenylcyclopropyl)ureido)methyl)benzenesulfonamide
|
||||
Synonyms |
CHEMBL453731
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C17H19N3O3S
|
||||
Canonical SMILES |
NS(=O)(=O)c1ccc(CNC(=O)NC2CC2c3ccccc3)cc1
|
||||
InChI |
InChI=1S/C17H19N3O3S/c18-24(22,23)14-8-6-12(7-9-14)11-19-17(21)20-16-10-15(16)13-4-2-1-3-5-13/h1-9,15-16H,10-11H2,(H2,18,22,23)(H2,19,20,21)
|
||||
InChIKey |
FHLMWCQAIOTWHF-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase II | Target Info | [1587926] | ||
Carbonic anhydrase IX | Target Info | [1587926] | |||
NetPath Pathway | IL4 Signaling Pathway | ||||
EGFR1 Signaling Pathway | |||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.